Rasha Abdelhady1
Sameh Saber2*
Mustafa Ahmed Abdel-Reheim3,4*
Mohannad Mohammad S. Alamri5
Jaber Alfaifi6Masoud I. E. Adam7Lobna A. Saleh8,9
Azza I. Farag10
Elsayed A. Elmorsy11,12Hend S. El-Wakeel13,14
Ahmed S. Doghish15,16
Mohamed E. Shaker17
Sara H. Hazem18Heba A. Ramadan19
Rabab S. Hamad20,21
Osama A. Mohammed8,22*- 1Pharmacology and Toxicology Department, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt
- 2Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt
- 3Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia
- 4Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt
- 5Department of Family Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia
- 6Department of Child Health, College of Medicine, University of Bisha, Bisha, Saudi Arabia
- 7Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia
- 8Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- 9Department of Pharmacology and Toxicology, Collage of Pharmacy, Taif University, Taif, Saudi Arabia
- 10Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
- 11Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia
- 12Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
- 13Physiology Department, Benha Faculty of Medicine, Benha University, Banha, Egypt
- 14Physiology Department, Al-baha Faculty of Medicine, Al-baha University, AlBaha, Saudi Arabia
- 15Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, Egypt
- 16Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt
- 17Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia
- 18Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
- 19Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Al Mansurah, Egypt
- 20Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, Saudi Arabia
- 21Central Laboratory, Theodor Bilharz Research Institute, Giza, Egypt
- 22Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha, Saudi Arabia
A Corrigendum on
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
by Abdelhady R, Saber S, Ahmed Abdel-Reheim M, Mohammad S. Alamri M, Alfaifi J, I. E. Adam M, A. Saleh L, I. Farag A, A. Elmorsy E, S. El-Wakeel H, S. Doghish A, E. Shaker M, H. Hazem S, A. Ramadan H, S. Hamad R and A. Mohammed O (2023). Front. Pharmacol. 14:1239025. doi: 10.3389/fphar.2023.1239025
In the published article, there was an error in affiliations 11 and 12. Instead of:
“11Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”
“12Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”
it should be:
“11Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”
“12Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ulcerative colitis, β-hydroxybutyrate, NLRP3 inflammasome, apoptosis, pyroptosis
Citation: Abdelhady R, Saber S, Abdel-Reheim MA, Mohammad S. Alamri M, Alfaifi J, Adam MIE, Saleh LA, Farag AI, Elmorsy EA, El-Wakeel HS, Doghish AS, Shaker ME, Hazem SH, Ramadan HA, Hamad RS and Mohammed OA (2024) Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis. Front. Pharmacol. 15:1382529. doi: 10.3389/fphar.2024.1382529
Received: 05 February 2024; Accepted: 07 February 2024;
Published: 13 March 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Abdelhady, Saber, Abdel-Reheim, Mohammad S. Alamri, Alfaifi, Adam, Saleh, Farag, Elmorsy, El-Wakeel, Doghish, Shaker, Hazem, Ramadan, Hamad and Mohammed. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sameh Saber, sampharm81@gmail.com; Mustafa Ahmed Abdel-Reheim, m.ahmed@su.edu.sa; Osama A. Mohammed, oamohamed@ub.edu.sa